Andrew D.C. LaFrence
CIK 1850633 · CHIEF FINANCIAL OFFICER · last filed 2026-06-12
Andrew D.C. LaFrence is a CHIEF FINANCIAL OFFICER who has filed 10 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for SKYT, was dated Jun 12, 2026. Across all open-market trades the lifetime net is +$29.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $490.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$490.5K
4
10
$29.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYT | Director | 15,732 | $31.18 | $490.5K | $0 | 2 | 2026-06-12 |
| NSYS | CHIEF FINANCIAL OFFICER | — | $14.46 | — | $0 | 1 | 2023-12-05 |
| KRMD | Chief Financial Officer | — | $4.01 | — | $0 | 1 | 2023-07-18 |
| Vyant Bio, Inc. (VYNT) Delisted | Chief Financial Officer | 12,823 | $0.19 | $2.5K | $29.8K | 6 | 2022-03-17 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | SKYT | Grant (A) | +4,304 | $0 | EDGAR |
| 2025-05-23 | SKYT | Grant (A) | +11,428 | $100.0K | EDGAR |
| 2023-12-05 | NSYS | Grant (A) | — | $0 | EDGAR |
| 2023-07-18 | KRMD | Grant (A) | — | $0 | EDGAR |
| 2022-03-17 | Vyant Bio, Inc. (VYNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-29 | Vyant Bio, Inc. (VYNT) Delisted | Buy (P) | +5,000 | $10.0K | EDGAR |
| 2021-11-24 | Vyant Bio, Inc. (VYNT) Delisted | Buy (P) | +5,000 | $10.0K | EDGAR |
| 2021-07-13 | Vyant Bio, Inc. (VYNT) Delisted | Other (J) | +56,117 | $0 | EDGAR |
| 2021-05-21 | Vyant Bio, Inc. (VYNT) Delisted | Buy (P) | +3,000 | $9.8K | EDGAR |
| 2021-04-01 | Vyant Bio, Inc. (VYNT) Delisted | Mixed | +56,202 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.